Angiotensin-converting enzyme tag single nucleotide polymorphisms in patients with intracerebral hemorrhage

Pharmacogenetics and Genomics

Volumn 21, Issue 3, 2011, Pages 136-141

  Dardiotis, Efthimios ^a,c   Jagiella, Jeremiasz ^e   Xiromerisiou, Georgia ^a,c   Dardioti, Maria ^c   Vogiatzi, Christina ^a   Urbanik, Andrzej ^e   Paterakis, Konstantinos ^b   Komnos, Apostolos ^d   Fountas, Kostas N ^b   Slowik, Agnieszka ^e   Hadjigeorgiou, Georgios M ^a,c  

^a Laboratory of Neurogenetics   (United States)

^b UNIVERSITY OF THESSALY   (Greece)

^c INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^d GENERAL HOSPITAL OF LARISSA   (Greece)

^e JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

angiotensin converting enzyme; genes; genetic association studies; intracerebral hemorrhage; polymorphism; tag single nucleotide polymorphisms

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CHROMOSOME POSITIONING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; GREECE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79951676060     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328343ab15     Document Type: Article

References (33)

1. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344: 1450-1460. (Pubitemid 32402103)
2. Alberts MJ, McCarron MO, Hoffmann KL, Graffagnino C. Familial clustering of intracerebral hemorrhage: a prospective study in North Carolina. Neuroepidemiology 2002; 21:18-21. (Pubitemid 34042857)
3. Yamada Y, Metoki N, Yoshida H, Satoh K, Ichihara S, Kato K, et al. Genetic risk for ischemic and hemorrhagic stroke. Arterioscler Thromb Vasc Biol 2006; 26:1920-1925. (Pubitemid 44305351)
4. Dardiotis E, Dardioti M, Xiromerisiou G, Paterakis K, Fountas K, Hadjigeorgiou GM. Genetic susceptibility to primary intracerebral haemorrhage. Eur Neurol Rev 2009; 4:44-48.
5. Duprez DA. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 2006; 24:983-991. (Pubitemid 43772300)
6. Kehoe PG, Miners S, Love S. Angiotensins in Alzheimer's disease-friend or foe? Trends Neurosci 2009; 32:619-628.
7. Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, Love S, et al. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 2008; 34:181-193. (Pubitemid 351327960)
8. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, Van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res 2006; 98:1123-1133. (Pubitemid 43948098)
9. Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002; 12:358-370. (Pubitemid 34743218)
10. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, et al. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 1994; 94:978-984.
11. Domingues-Montanari S, Hernandez-Guillamon M, Fernandez-Cadenas I, Mendioroz M, Boada M, Munuera J, et al. ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy. Neurobiol Aging 2010. doi:10.1016/j.neurobiolaging.2010.01.019.
12. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, Witteman JC. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis. Stroke 2003; 34:1634-1639. (Pubitemid 36842616)
13. Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, Prince JA, et al. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am J Epidemiol 2005; 162:305-317. (Pubitemid 41389712)
14. Slowik A, Turaj W, Dziedzic T, Haefele A, Pera J, Malecki MT, et al. DD genotype of ACE gene is a risk factor for intracerebral hemorrhage. Neurology 2004; 63:359-361. (Pubitemid 38971144)
15. Catto A, Carter AM, Barrett JH, Stickland M, Bamford J, Davies JA, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 1996; 27:435-440. (Pubitemid 26081438)
16. Dikmen M, Gunes HV, Degirmenci I, Ozdemir G, Basaran A. Are the angiotensin-converting enzyme gene and activity risk factors for stroke? Arq Neuropsiquiatr 2006; 64:211-216. (Pubitemid 43979063)
17. Lin JJ, Yueh KC, Lin GY, Chang DC, Chang CY, Shieh HL, et al. Lack of association between angiotensin I-converting enzyme gene deletion polymorphism and cerebrovascular disease in Taiwanese. J Formos Med Assoc 2000; 99:895-901.
18. Nakata Y, Katsuya T, Rakugi H, Takami S, Sato N, Kamide K, et al. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens 1997; 10:1391-1395. (Pubitemid 28078743)
19. Chen CM, Chen YC, Wu YR, Hu FJ, Lyu RK, Chang HS, et al. Angiotensin-converting enzyme polymorphisms and risk of spontaneous deep intracranial hemorrhage in Taiwan. Eur J Neurol 2008; 15:1206-1211.
20. Peck G, Smeeth L, Whittaker J, Casas JP, Hingorani A, Sharma P. The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults. PLoS One 2008; 3:e3691.
21. Li Y, Chen F, Zhou L, Coulter D, Chen C, Sun Z, et al. COC use, ACE/AGT gene polymorphisms, and risk of stroke. Pharmacogenet Genomics 2010; 20:298-306.
22. Suehiro T, Morita T, Inoue M, Kumon Y, Ikeda Y, Hashimoto K. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet 2004; 115:91-96. (Pubitemid 39010922)
23. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290(Pt 1):33-40. (Pubitemid 23081197)
24. Danser AH, Schalekamp MA, Bax WA, Van den Brink AM, Saxena PR, Riegger GA, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92:1387-1388.
25. Hamdi HK, Castellon R. A genetic variant of ACE increases cell survival: a new paradigm for biology and disease. Biochem Biophys Res Commun 2004; 318:187-191. (Pubitemid 38526263)
26. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346. (Pubitemid 20370444)
27. Dardiotis E, Hadjigeorgiou GM, Dardioti M, Scarmeas N, Paterakis K, Aggelakis K, et al. Alpha-1 antichymotrypsin gene signal peptide a/t polymorphism and primary intracerebral hemorrhage. Eur Neurol 2008; 59:307-314. (Pubitemid 351543131)
28. Pera J, Slowik A, Dziedzic T, Pulyk R, Wloch D, Szczudlik A. Glutathione peroxidase 1 C593 T polymorphism is associated with lobar intracerebral hemorrhage. Cerebrovasc Dis 2008; 25:445-449. (Pubitemid 351754641)
29. Carter KW, McCaskie PA, Palmer LJ. SimHap GUI: an intuitive graphical user interface for genetic association analysis. BMC Bioinformatics 2008; 9:557.
30. Schelleman H, Klungel OH, Witteman JC, Breteler MM, Hofman A, van Duijn CM, et al. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke. Pharmacogenomics J 2008; 8:400-407.
31. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001; 68:1139-1148. (Pubitemid 32424413)
32. Narita I, Goto S, Saito N, Song J, Omori K, Kondo D, et al. Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism. J Med Genet 2003; 40:e130.
33. Chung CM, Wang RY, Chen JW, Fann CS, Leu HB, Ho HY, et al. A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor. Pharmacogenomics J 2010; 10:537-544.